Food delays absorption of erythromycin base. After 500 mg of the 2′-ethylsuccinyl ester, mean peak plasma levels at 1–2 h were 1.5 mg/L. In subjects given 1 g of the 2′-ethylsuccinate every 12 h for seven doses, the mean plasma concentration 1 h after the last dose was around ...
To study the absorption of different preparations of erythromycin in the fasting state, 500 mg stearate (tablets) and 500 mg base (enteric-coated pellets) were given immediately before a standardised breakfast to 24 young, healthy volunteers in an open, random, cross-over trial. The serum peak...
500 mg Erythrocin® Lactobionate-I.V. (erythromycin lactobionate for injection, USP) every 6 hours for 3 days, followed by 500 mg of erythromycin base orally every 12 hours for 7 days. Intestinal Amebiasis Adults 500 mg every 12 hours or 250 mg every 6 hours for 10 days to 14 ...
Dosage 500 mg P. O. QID for 7 day Woodward and Fisher (1999) Base Chlamydial Infections Dosage 800 mg P. O. QID for 7 day Woodward and Fisher (1999) Ethyl succinate. Endocarditis Dosage 800 mg Orally, 2 hrs before the procedure, then half dose 6 hrs. later. Dajani et al (1990)...
In cirrhotic patients receiving 500 mg of the base, peak plasma levels were higher and earlier than in healthy volunteers (2.0 and 1.5 mg/L at 4.6 and 6.3 h, respectively). The apparent elimination half-life was 6.6 h. It is possible that the smaller excretion of the 2′-propionyl ester...
申请号 062999 申请类型 ANDA 商品名 E-Base 活性成分 Erythromycin 申请机构 Barr 批准日期 1988-11-25 申请备注 数据来源 产品信息 产品号 商品名 活性成分 剂型 给药途径 规格 参比制剂 标准制剂 市场状态 治疗等效性代码 001 E-Base Erythromycin Tablet, Delayed Release Oral 500mg No No Discontinued ...
Eyrthromycin base 500 mg b.i.d. 15–45% 3.5 2 15 2.5 0.64 65–90 Clarithromycin 500 mg b.i.d. 55% 2.7 2.6 40 4.7 3.1 70 Azithromycin 500 mg qd, day 1 250 mg qd, days 2–5 37% 0.24 3.2 2.1 40–68 31 7–50 Roxithromycin 300 mg qd 78% 10 1.2 130 12 0.87 73–90 D...
剂型或给药途径 TABLET;ORAL 规格 EQ 500MG BASE 治疗等效代码 参比药物 否 批准日期 Approved Prior to Jan 1, 1982 申请机构 MYLAN PHARMACEUTICALS INC 7 药品名称 ERYTHROMYCIN STEARATE 申请号 061591 产品号 001 活性成分 ERYTHROMYCIN STEARATE 市场状态 停止上市 剂型或给药途径 TABLET;ORAL 规格 EQ 250MG...
RNAse A 溶液(100mg/ml) 500μl R4246-25 RNAse A 25mg R4246-50 RNAse A 50mg T8030-500 三羟甲基氨基甲烷Tris base 500g T8030-1000 三羟甲基氨基甲烷Tris base 1Kg S8130-100 十二烷基硫酸钠SDS 100g S8130-500 十二烷基硫酸钠SDS 500g T16015-25 SSCS溶液 25ml T16015-...
002 Erythromycin Erythromycin Lactobionate Injectable Injection eq 1gm base/vial No No Discontinued 1 Erythromycin Erythromycin Lactobionate Injectable Injection eq 500mg base/vial No No undefined 2 Erythromycin Erythromycin Lactobionate Injectable Injection eq 1gm base/vial No No undefined ...